The IPO market performance in December
Compared with the twelve new stocks listed on HKEX in November, the number of new listings rose significantly in December to 25 new stocks listed on HKEX. As of December 31st, the overall performance of the IPO market was divided. Among them, NUOBIKAN (2635.HK) and QINGSONG HEALTH (2661.HK) saw a 368% and 202% increase in share price, respectively, since listing. Whereas B&K CORP-B (2396.HK) and BENQ HOLDING (2581.HK) saw a 58% and 56% decrease in share price since listing, respectively.
Phillip Hong Kong Newly Listed Equities Index ETF (2835.HK)
The ETF aims to fully replicate the Solactive Hong Kong Newly Listed Equities Index, a rules-based equity benchmark designed to track the performance of securities that had a recent initial public offering or new listing on the main board of HKEX. The index is rebalanced quarterly, incorporating securities with IPOs or new listings within the last 756 business days, aiming for a total of 50 securities based on free-float market capitalization. The index also undergoes monthly IPO reviews to include recent IPOs, subject to liquidity and market capitalisation criteria.
December Monthly Review
Solactive HK Newly listed Equities Index included PONY-W (2026.HK), PEGBIO CO-B (2565.HK), WERIDE-W (800.HK), TRANSTHERA-B (2617.HK), MININGLAMP-W (2718.HK), CHUANGXIN IND (2788.HK), SERES (9927.HK), WELLCELL HOLD (2477.HK), SOFTCARE (2698.HK), MIRXES-B (2629.HK), and YUNJI (2670.HK) in December through the quarterly rebalancing mechanism. And it also removed TME-SW (1698.HK), LEAPMOTOR (9863.HK), CHERY AUTO (9973.HK), GIANT BIOGENE (2367.HK), BOSS ZHIPIN-W (2076.HK), CALB (3931.HK), CTG DUTY-FREE (1880.HK), BLOKS (325.HK), LEADS BIOLABS-B (9887.HK), ZJLD (6979.HK), SUNSHINE PHARMA (6887.HK), ZENERGY (3677.HK), CAOCAO INC (2643.HK), QUNABOX GROUP (917.HK), INNOGEN-B (2591.HK). The current number of constituent stocks has decreased from 54 to 50.
PONY-W (2026.HK) has been committed to developing advanced Level 4 autonomous driving technology, with a focus on autonomous driving mobility services. The company is the only Level 4 autonomous driving technology company to have obtained all regulatory permits available and required to provide public-facing robotaxi services in all four Tier-1 cities as of the Latest Practicable Date, operating a fleet of over 720 self-owned robotaxis as of the same date, which accumulated over 48.6 million kilometres of autonomous driving mileage, including over 11.5 million kilometres of driverless mileage. The company is also the first in China to receive approval for driverless robot truck platooning tests on cross-provincial highways in December 2024, operating a fleet of over 170 self-owned and leased robot trucks as of the Latest Practicable Date.
As of December 31st, 2024, the company’s revenue in 2024 was 75.0 million dollars (USD, the same below), a year-on-year increase of 4.3%. Gross profit was 11.4 million, a decrease of 32.5% YoY, due to the increase in cost of revenue exceeding the increase in revenue; the gross profit margin decreased from 23.5% in 2023 to 15.2% in 2024. The loss attributable to the company’s equity holders in 2024 was 275.0 million, an increase of 119.5% YoY, mainly due to a significant increase in operating expenses resulting from increased R&D investment to support the joint development of the seventh-generation autonomous taxi with OEM partners.
Top 10 Holdings
This month, the Phillip Hong Kong Newly Listed Equities Index ETF’s top ten holdings changed. TME-SW (1698.HK), LEAPMOTOR (9863.HK), and CHERY AUTO (9973.HK) fell out of the top ten holdings due to quarterly rebalancing mechanism, while PONY-W (2026.HK), INNOSCIENCE (2577.HK), and WUXI XDC (2268.HK) became the new top ten holdings. The following industries are currently the focus of the index: industrials (including CATL, J&T EXPRESS-W, and UBTECH ROBOTICS), information technology (including HORIZON ROBOT, PONY-W, and INNOSCIENCE), and consumer discretionary (including MIDEA, LAOPU GOLD, and HESAI-W). The following figures show the top 10 holdings and sector breakdown of the Phillip HK Newly Listed Equities Index:

Key Components Update
Top constituent movers in December:

Bottom constituent movers in December:

The Phillip HK Newly Listed Index ETF (2835.HK) monthly performance for December
The Phillip HK Newly Listed Index ETF (2835.HK) recorded a 1.79% monthly decrease in December, underperforming the Hang Seng Index’s (HSI) 0.88% monthly decrease and the Hang Seng Tech Index’s (HSTI) 1.48% monthly decrease. As of December 31st, this ETF had grown 22.64% since its listing, underperforming the HSI’s rose of 42.45% and the HSTI’s rose of 47.38%.

The following table compares the performance of the Phillip Hong Kong IPO Index ETF (2835.HK), the Hang Seng Index (HSI), and the Hang Seng Tech Index (HSTECH):

The IPO market performance in November
There were twelve new stocks listed on HKEX in November, which is the same as the number of listings in October. As of November 30th, the overall performance of the IPO market was divided. Among them, VIGONVITA-B (2630.HK) and QUANTGROUP (2685.HK) saw a 110% and 77% increase in share price, respectively, since listing. Whereas JOYSON ELEC (699.HK) and WERIDE-W (800.HK) saw a 25% and 23% decrease in share price since listing, respectively.
Phillip Hong Kong Newly Listed Equities Index ETF (2835.HK)
The ETF aims to fully replicate the Solactive Hong Kong Newly Listed Equities Index, a rules-based equity benchmark designed to track the performance of securities that had a recent initial public offering or new listing on the main board of HKEX. The index is rebalanced quarterly, incorporating securities with IPOs or new listings within the last 756 business days, aiming for a total of 50 securities based on free-float market capitalization. The index also undergoes monthly IPO reviews to include recent IPOs, subject to liquidity and market capitalisation criteria.
November Monthly Review
Solactive HK Newly Listed Equities Index included CHERY AUTO (9973.HK), SANY HEAVY IND (6031.HK), PATEO (2889.HK), and 160 HEALTH (2656.HK) in November through the fast-track mechanism. And it also removed BEAUTYFARM MED (2373.HK). The current number of constituent stocks has increased from 51 to 54.
HESAI-W (2525.HK) is a passenger vehicle company that designs, develops, manufactures, and sells a diverse and expanding portfolio of passenger vehicles, including internal combustion engine (ICE) vehicles and new energy vehicles (NEVs), to cater to the distinct and evolving needs and preferences of customers in both the domestic and overseas markets. The company has five major brands: CHERY, JETOUR, EXEED, iCAR and LUXEED. As the signature brand, CHERY is positioned as a first-rated car brand of safety, comfort and quality for the mass market and family use; JETOUR targets customers who are passionate about family travel and outdoor leisure; EXEED targets customers who value performance and elegance; iCAR targets Generation Z customers who are keen on technology and value freedom; and LUXEED targets customers who pursue intelligence, performance, and innovation. According to data, the company is the second largest Chinese domestic brand passenger vehicle company and the 11th largest passenger vehicle company globally in terms of global sales volume of passenger vehicles in 2024.
As of December 31st, 2024, the company’s revenue in 2024 was 269.90 billion yuan (RMB, the same below), a year-on-year increase of 65.4%. Gross profit was 10.22 billion yuan, an increase of 39.2% YoY; the gross profit margin decreased from 16.0% in 2023 to 13.5% in 2024. The net profit attributable to the company’s equity holders in 2024 was 14.33 billion yuan, an increase of 37.2% YoY. The company’s gross profit increased, but the gross profit margin decreased, mainly due to changes in the product mix and the reduction in gross profit margin caused by overseas taxes on imported cars.
Top 10 Holdings
This month, the Phillip Hong Kong Newly Listed Equities Index ETF’s top ten holdings changed. BOSS ZHIPIN-W (2076.HK) and WUXI XDC (2268.HK) fell out of the top ten holdings due to price movement, while CHERY AUTO (9973.HK) and LAOPU GOLD (6181.HK) became the new top ten holdings. The following industries are currently the focus of the index: consumer discretionary (including MIDEA, LEAPMOTOR, and CHERY AUTO), industrials (including CATL, J&T EXPRESS-W, and UBTECH ROBOTICS), and information technology (including HORIZON ROBOT, INNOSCIENCE, and KINGSOFT CLOUD). The following figures show the top 10 holdings and sector breakdown of the Phillip HK Newly Listed Equities Index:
Key Components Update
Top constituent movers in November:

Bottom constituent movers in November:

The Phillip HK Newly Listed Index ETF (2835.HK) monthly performance for November
The Phillip HK Newly Listed Index ETF (2835.HK) recorded a 7.71% monthly decrease in November, underperforming the Hang Seng Index’s (HSI) 0.18% monthly decrease and the Hang Seng Tech Index’s (HSTI) 5.23% monthly decrease. As of November 30th, this ETF had grown 24.87% since its listing, underperforming the HSI’s rose of 43.72% and the HSTI’s rose of 49.60%.

The following table compares the performance of the Phillip Hong Kong IPO Index ETF (2835.HK), the Hang Seng Index (HSI), and the Hang Seng Tech Index (HSTECH):

The IPO market generally performed well in October
There were twelve new stocks listed on HKEX in October, which continued to increase in comparison to the ten initial public offerings (IPOs) in September. As of October 31st, despite FIBOCOM (638.HK) saw a 9% decrease in share price since listing, other IPOs all saw rise in share prices. Among them, XUANZHUBIO-B (2575.HK) and DEEPEXI TECH (1384.HK) saw a 448% and 327% increase in share price, respectively, since listing.
Phillip Hong Kong Newly Listed Equities Index ETF (2835.HK)
The ETF aims to fully replicate the Solactive Hong Kong Newly Listed Equities Index, a rules-based equity benchmark designed to track the performance of securities that had a recent initial public offering or new listing on the main board of HKEX. The index is rebalanced quarterly, incorporating securities with IPOs or new listings within the last 756 business days, aiming for a total of 50 securities based on free-float market capitalization. The index also undergoes monthly IPO reviews to include recent IPOs, subject to liquidity and market capitalisation criteria.
October Monthly Review
Solactive HK Newly Listed Equities Index included HESAI-W (2525.HK) in October through the fast-track mechanism. The current number of constituent stocks has increased from 50 to 51.
HESAI-W (2525.HK) is a global leader in three-dimensional light detection and ranging (LiDAR) solutions. The company design, develop, manufacture, and sell advanced LiDAR products. According to the data, it was the No. 1 LiDAR supplier globally in each of 2022, 2023 and 2024 in terms of revenue. And it achieved the highest gross margin and gross profit among LiDAR companies worldwide in 2022, 2023, and 2024. By December 2024, the company became the first LiDAR company globally to achieve 100,000 units shipment in a single month.
As of December 31st, 2024, the company’s revenue in 2024 was 20.77 billion yuan (RMB, the same below), a year-on-year increase of 10.7%. Gross profit was 8.85 billion, an increase of 33.7% YoY; the gross profit margin rose from 35.2% in 2023 to 42.6% in 2024. The net loss attributable to the company’s equity holders in 2024 was narrowed significantly to 1.02 billion, a decrease of 364.8% YoY. The increase in the company’s gross profit margin is primarily attributable to effective cost optimization due to product iteration and economies of scale for both ADAS and Robotics LiDAR products.
Top 10 Holdings
This month, the Phillip Hong Kong Newly Listed Equities Index ETF’s top ten holdings changed. GIANT BIOGENE (2367.HK) and INNOSCIENCE (2577.HK) fell out of the top ten holdings due to price movement, while BOSS ZHIPIN-W (2076.HK) and UBTECH ROBOTICS (9880.HK) became the new top ten holdings. The following industries are currently the focus of the index: industrials (including CATL, J&T EXPRESS-W, and UBTECH ROBOTICS), consumer discretionary (including MIDEA, LEAPMOTOR, and LAOPU GOLD), and information technology (including HORIZON ROBOT, INNOSCIENCE, and KINGSOFT CLOUD). The following figures show the top 10 holdings and sector breakdown of the Phillip HK Newly Listed Equities Index:

Key Components Update
Top constituent movers in October:

Bottom constituent movers in October:

The Phillip HK Newly Listed Index ETF (2835.HK) monthly performance for October
The Phillip HK Newly Listed Index ETF (2835.HK) recorded an 8.69% monthly decrease in October, underperforming the Hang Seng Index’s (HSI) 3.53% monthly decrease and the Hang Seng Tech Index’s (HSTI) 8.62% monthly decrease. As of October 31st, this ETF had grown 35.30% since its listing, underperforming the HSI’s rose of 43.99% and the HSTI’s rose of 57.86%.

The following table compares the performance of the Phillip Hong Kong IPO Index ETF (2835.HK), the Hang Seng Index (HSI), and the Hang Seng Tech Index (HSTECH):

The IPO market generally performed well in September
The total number of new listings in September increased in comparison to the six initial public offerings (IPOs) in August, as there were ten new stocks listed on HKEX. As of September 30th, despite AUX ELECTRIC (2580.HK) seeing an 18% decrease in share price since listing, other IPOs all saw a rise in share prices. Among them, HIPINE (2583.HK) and 160 HEALTH (2656.HK) saw a 258% and 154% increase in share price, respectively, since listing.
Phillip Hong Kong Newly Listed Equities Index ETF (2835.HK)
The ETF aims to fully replicate the Solactive Hong Kong Newly Listed Equities Index, a rules-based equity benchmark designed to track the performance of securities that had a recent initial public offering or new listing on the main board of HKEX. The index is rebalanced quarterly, incorporating securities with IPOs or new listings within the last 756 business days, aiming for a total of 50 securities based on free-float market capitalization. The index also undergoes monthly IPO reviews to include recent IPOs, subject to liquidity and market capitalisation criteria.
September Monthly Review
Solactive HK Newly Listed Equities Index included BOSS ZHIPIN-W (2076.HK), SKB BIO-B (6990.HK), LAOPU GOLD (6181.HK), UNISOUND (9678.HK), INNOGEN-B (2591.HK), SF HOLDING (6936.HK), REPT BATTERO (666.HK), ZENERGY (3677.HK), SUNSHINE INS (6963.HK), and SUNSHINE PHARMA (6887.HK) in September through the quarterly rebalancing mechanism. And it also removed BEKE-W (2423.HK), MNSO (9896.HK), TRANSTHERA-B (2617.HK), MIRXES-B (2629.HK), STARPLUS LEGEND (6683.HK), TIANQI LITHIUM (9696.HK), SYNAGISTICS (2562.HK), CR BEVERAGE (2460.HK), TS LINES (2510.HK), WELLCELL HOLD (2477.HK), GUOFUHEE (2582.HK), LAEKNA-B (2105.HK), MICROPORT NEURO (2172.HK), RIMAG GROUP (2522.HK), TANWAN (9890.HK), YSB (9885.HK), HEALTHYWAY INC (2587.HK), GREEN TEA GROUP (6831.HK), VOICECOMM (2495.HK), DRINDA (2865.HK), and ETERNAL BEAUTY (6883.HK). The current number of constituent stocks has decreased from 61 to 50.
BOSS ZHIPIN-W (2076.HK) was first introduced and listed on HKEX in 2022, then it issued new shares for subscription in June 2025 and was therefore re-included in the Newly Listed Equities Index. The company pioneered the “direct recruitment model”, leveraging a mobile-native platform to innovatively integrate two-way communication and referrals into the online recruitment process, recreating the essence of a real-world recruitment scenario. The company was the first to adopt this model in China’s online recruitment industry. The development of this innovative business model, fundamentally different from existing models from the outset, has since transformed China’s online recruitment industry and user behaviour.
As of June 30th, 2025, the company’s half-year revenue in 2025 was 4.03 billion yuan (RMB, the same below), a year-on-year increase of 11.2%. Gross profit was 1.09 billion, an increase of 136.0% YoY; the gross profit margin rose from 12.8% in 2024 to 27.1% in 2025 for the same period. The increase in the company’s revenue and gross profit was mainly driven by the growth of paying enterprise customers and the reduction of expenses such as operating costs and marketing expenses.
Top 10 Holdings
This month, the Phillip Hong Kong Newly Listed Equities Index ETF’s top ten holdings changed. BEKE-W (2423.HK) fell out of the top ten holdings due to listing for over 3 years, while WUXI XDC (2268.HK) became the new top ten holding. The following industries are currently the focus of the index: industrials (including CATL, J&T EXPRESS-W, and UBTECH ROBOTICS), consumer discretionary (including LEAPMOTOR, MIDEA, and LAOPU GOLD), and information technology (including HORIZON ROBOT, INNOSCIENCE, and KINGSOFT CLOUD). The following figures show the top 10 holdings and sector breakdown of the Phillip HK Newly Listed Equities Index:

Key Components Update
Top constituent movers in September:

Bottom constituent movers in September:

The Phillip HK Newly Listed Index ETF (2835.HK) monthly performance for September
The Phillip HK Newly Listed Index ETF (2835.HK) recorded a 9.79% monthly increase in September, overperforming the Hang Seng Index’s (HSI) 7.09% monthly increase but underperforming the Hang Seng Tech Index’s (HSTI) 13.95% monthly increase. As of September 30th, this ETF had grown 48.18% since its listing, underperforming the HSI’s rose of 49.26% and the HSTI’s rose of 72.75%.

The following table compares the performance of the Phillip Hong Kong IPO Index ETF (2835.HK), the Hang Seng Index (HSI), and the Hang Seng Tech Index (HSTECH):

The IPO market generally performed well in August
The total number of listings in August continued to reduce in comparison to the ten initial public offerings (IPOs) in July, as there were six new stocks listed on HKEX. As of August 31st, despite SUNSHINE PHARMA (6887.HK) saw a 10% decrease in share price since listing, other IPOs all saw rise in share prices. Among them, AB&B BIO-TECH-B (2627.HK) and JIAXIN INTL RES (3858.HK) saw a 295% and 175% increase in share price, respectively, since listing.
Phillip Hong Kong Newly Listed Equities Index ETF (2835.HK)
The ETF aims to fully replicate the Solactive Hong Kong Newly Listed Equities Index, a rules-based equity benchmark designed to track the performance of securities that had a recent initial public offering or new listing on the main board of HKEX. The index is rebalanced quarterly, incorporating securities with IPOs or new listings within the last 756 business days, aiming for a total of 50 securities based on free-float market capitalization. The index also undergoes monthly IPO reviews to include recent IPOs, subject to liquidity and market capitalisation criteria.
August Monthly Review
Solactive HK Newly listed Equities Index included GEEKPLUS-W (2590.HK), HAITIAN FLAV (3288.HK), LEADS BIOLABS-B (9887.HK), and LENS (6613.HK) in August through the fast-track mechanism. The current number of constituent stocks has increased from 57 to 61.
GEEKPLUS-W (2590.HK) is a leader in the global autonomous mobile robot (“AMR”) market. The company offers a series of AMR solutions to empower warehouse fulfilment and industrial material transport, enhancing supply chain efficiency while reducing reliance on manual labour. According to data, as of December 31st, 2024, the company has shipped approximately 56,000 AMRs across over 40 countries and regions worldwide. In 2024, it occupied a 9.0% market share in the overall global warehouse fulfilment AMR solution market and approximately 1% market share of the global warehouse automation solution market.
As of December 31st, 2024, the company’s revenue in 2024 was 2.41 billion yuan (RMB, the same below), a year-on-year increase of 12.4%. Gross profit was 837.17 million, an increase of 27.0% YoY; the gross profit margin rose from 30.8% in 2023 to 34.8% in 2024. The company’s revenue growth stems from an increase in the number of customers and an increase in average revenue per customer, which led to increased sales of the company’s warehouse fulfilment AMR solutions. Furthermore, the company’s gross margin in 2024 also increased due to a steady decline in costs, driven by continued cost reductions through product design optimization and supply chain sourcing.
Top 10 Holdings
This month, the Solactive Hong Kong Newly Listed Equities Index’s top ten holdings changed. DUALITYBIO-B (9606.HK) and MIXUE GROUP (2097.HK) fell out of the top ten holdings due to price fluctuations, while INNOSCIENCE (2577.HK) and XTALPI (2228.HK) became the new top ten holdings. The following industries are currently the focus of the index: industrials (including J&T EXPRESS-W, CATL, and TUHU-W), information technology (including HORIZON ROBOT, INNOSCIENCE, and KINGSOFT CLOUD), and consumer discretionary (including MIDEA, LEAPMOTOR, and MIXUE GROUP). The following figures show the top 10 holdings and sector breakdown of the Phillip HK Newly Listed Equities Index:

Key Components Update
Top constituent movers in August:

Bottom constituent movers in August:

The Phillip HK Newly Listed Index ETF (2835.HK) monthly performance for August
The Phillip HK Newly Listed Index ETF (2835.HK) recorded a 10.26% monthly increase in August, overperforming the Hang Seng Index’s (HSI) 1.23% monthly increase and the Hang Seng Tech Index’s (HSTI) 4.06% monthly increase. As of August 31st, this ETF had grown 34.96% since its listing, underperforming the HSI’s rose of 39.38% and the HSTI’s rose of 51.61%.

The following table compares the performance of the Phillip Hong Kong IPO Index ETF (2835.HK), the Hang Seng Index (HSI), and the Hang Seng Tech Index (HSTECH):

The IPO market showed a trend of differentiation in July
The total number of listings in July slightly reduced in comparison to the fifteen initial public offerings (IPOs) in June, but there were still ten new stocks listed on HKEX, and the overall performance of the IPO market was divided. As of July 31st, LEADS BIOLABS-B (9887.HK) and FORTIOR (1304.HK) saw a 106% and 26% increase in share price, respectively, since listing. Whereas CLOUDBREAK-B (2592.HK) and DAZHONG DENTAL (2651.HK) saw a 47% and 28% decrease in share price since listing, respectively.
Phillip Hong Kong Newly Listed Equities Index ETF (2835.HK)
The ETF aims to fully replicate the Solactive Hong Kong Newly Listed Equities Index, a rules-based equity benchmark designed to track the performance of securities that had a recent initial public offering or new listing on the main board of HKEX. The index is rebalanced quarterly, incorporating securities with IPOs or new listings within the last 756 business days, aiming for a total of 50 securities based on free-float market capitalization. The index also undergoes monthly IPO reviews to include recent IPOs, subject to liquidity and market capitalisation criteria.
July Monthly Review
Solactive HK newly listed Equities Index included HENGRUI PHARMA (1276.HK), SANHUA (2050.HK), TRANSTHERA-B (2617.HK), MIRXES-B (2629.HK), CAOCAO INC (2643.HK), ETERNAL BEAUTY (6883.HK), GREEN TEA GROUP (6831.HK), and DRINDA (2865.HK) in July through the fast-track mechanism. And it also removed ZENERGY (3677.HK). The current number of constituent stocks has increased from 50 to 57.
HENGRUI PHARMA (1276.HK) is a leading innovative global pharmaceutical company rooted in China. The company strategically focus on comprehensive therapeutic areas with significant unmet medical needs and growth potential. These mainly include oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. According to data, the aggregate global pharmaceutical market corresponding to the company’s major therapeutic areas in 2023 was US$845.8 billion, accounting for 57.4% of the overall global pharmaceutical market for the same year; and it is expected to grow at a CAGR of 6.4% from 2023 to 2028, surpassing the CAGR of 5.7% for the overall global pharmaceutical market growth during the same period.
As of December 31st, 2024, the company’s revenue in 2024 was 279.85 billion yuan (RMB, the same below), a year-on-year decrease of 22.6%. Gross profit was 241.36 billion, an increase of 25.1% YoY; the gross profit margin rose from 84.6% in 2023 to 86.2% in 2024. The profit for the year attributable to the company’s equity holders was 63.37 billion, an increase of 47.3% YoY. The company’s revenue growth this year mainly benefited from its expansion in the global and Chinese pharmaceutical markets and growth in major therapeutic areas, continuous development and commercialization of new drugs and product portfolio strengthening, effective control of costs and expenses, entry into medical insurance plans and participation in drug procurement competition in China’s public medical institutions.
Top 10 Holdings
This month, the Solactive Hong Kong Newly Listed Equities Index’s top ten holdings changed. DOBOT (2432.HK) fell out of the top ten holdings due to market fluctuations, while DUALITYBIO-B (9606.HK) became the new top ten holdings. The following industries are currently the focus of the index: industrials (including J&T EXPRESS-W, CATL, and DOBOT), consumer discretionary (including MIDEA, LEAPMOTOR, and MIXUE GROUP), and information technology (including HORIZON ROBOT, KINGSOFT CLOUD, and INNOSCIENCE). The following figures show the top 10 holdings and sector breakdown of the Phillip HK Newly Listed Equities Index:

Key Components Update
Top constituent movers in July:

Bottom constituent movers in July:

The Phillip HK Newly Listed Index ETF (2835.HK) monthly performance for July
The Phillip HK Newly Listed Index ETF (2835.HK) recorded a 7.31% monthly increase in July, overperforming the Hang Seng Index’s (HSI) 2.91% monthly increase and the Hang Seng Tech Index’s (HSTI) 3.54% monthly increase. As of July 31st, this ETF had grown 22.40% since its listing, underperforming the HSI’s rose of 37.69% and the HSTI’s rose of 45.70%.
